Company
L'EQ Score indique l'activité et l'attractivité de l'entreprise sur la plateforme : complétude du profil, actualités, likes, follows, appartenance à un ou plusieurs labels ou communautés, nombre de membres de son réseau, etc.
New Arthroscopic Method to Treat and Cure early Arthrosis for the veterinary market (ready) and the medical human market Be the leader in developing laser-based innovative solutions for arthrosis treatment.
Genève, Genève, Switzerland
Send a message
Anglais
Anglais
Laserix was founded by Prof. Pierre Ravussin, physicist engineer from the Federal Institute of Technology of Lausanne (EPFL), and Key Opinion Leader (KOL) in the field of lasers, Dr. Gilbert Mouthon, Professor at the Ecole Nationale Vétérinaire de Maison Alfort (France) and Mr. Claude Daenzer (†).
Laserix SA is specialized in the development and manufacturing of lasers for veterinary and medical applications. Cartilex, for the treatment of osteoarthritis in horses and dogs then...
Laserix was founded by Prof. Pierre Ravussin, physicist engineer from the Federal Institute of Technology of Lausanne (EPFL), and Key Opinion Leader (KOL) in the field of lasers, Dr. Gilbert Mouthon, Professor at the Ecole Nationale Vétérinaire de Maison Alfort (France) and Mr. Claude Daenzer (†).
Laserix SA is specialized in the development and manufacturing of lasers for veterinary and medical applications. Cartilex, for the treatment of osteoarthritis in horses and dogs then humans. Following preliminary testing at Ecole Nationale Vétérinaire d'Alfort and Institut of Pathology of Bern University, the use of Cartilex on racing horses with osteoarthritis have started in 2014, generating spectacular results.
The priority is Cartilex, the patented technique to cure early arthrotic articular.
Board of directors
Scientific advisory board
Capital action CHF 665’375.-
1
Like